A new initiative to introduce COVID-19 oral antivirals and national test-and-treat programmes in 10 countries in Africa and Southeast Asia was launched on Wednesday by the COVID Treatment Quick Start Consortium. The consortium will support governments to introduce and scale up access to antivirals, starting with Pfizer’s Paxlovid, in high-risk populations in Ghana, Kenya, Laos, […] Continue reading ->
The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading ->
Pfizer’s COVID-19 oral antiviral Paxlovid was found to reduce the mortality rate among people over the age of 65 by 81% in a new Israeli study published Wednesday in the New England Journal of Medicine. However, the study also found no significant benefit of the drug in patients aged 64 and younger. It is the […] Continue reading ->
The Omicron-targeted boosters are coming. Almost 250 days since Omicron became the dominant variant in the US, Pfizer and BioNTech on Monday officially announced that they’ve requested an Emergency Use Authorization (EUA) from the US Food and Drug Administration for their booster dose of an Omicron BA.4/BA.5-adapted bivalent vaccine for those 12 and older. The […] Continue reading ->
An expert panel of advisers to the World Health Organization (WHO) has recommended that countries consider a second COVID-19 booster dose for older, at-risk and immunocompromised people, echoing guidance provided by European and U.S. regulators months earlier. WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization released its updated recommendations on Thursday, a week after […] Continue reading ->
Desperately ill patients died alone in hospitals, tended in their final hours by burnt-out health workers. An avalanche of misinformation undermined care, and non-COVID patients and programmes faced cancelled appointments and treatment delays. These are some of the factors that undermined patient safety during COVID-19, according to a rapid review by the World Health Organization […] Continue reading ->
MONTREAL – Progress against HIV has slowed down during the COVID-19 pandemic as donors pull back, countries test and treat fewer people and miss key targets, UNAIDS revealed on Wednesday. “Progress in prevention and treatment is faltering around the world, putting millions of people in grave danger. Eastern Europe and central Asia, Latin America, and […] Continue reading ->
(DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading ->
After missing the target to vaccinate 70% of people in every country against COVID by July 2022, WHO’s new vaccine strategy prioritises 100% coverage for health workers and older people – but admits that every country will have to decide for itself. The World Health Organization has published an update to the Global COVID-19 Vaccination […] Continue reading ->
WHO has issued stiff, dual warnings over a surging global rate of COVID infections alongside a still-expanding outbreak of Monkeypox. The latter is set to be the focus of a discussion by a WHO Emergency Committee meeting Thursday, as the committee reconvenes to decide if a public health emergency should be declared over the virus […] Continue reading ->